When was Aviir founded?
Aviir was founded in 2005.
Where is Aviir's headquarters?
Aviir's headquarters is located at 9805 Research Drive, Irvine.
What is Aviir's latest funding round?
Aviir's latest funding round is Series D - III.
How much did Aviir raise?
Aviir raised a total of $65.19M.
Who are the investors of Aviir?
Investors of Aviir include Aberdare Ventures, Bay City Capital, New Leaf Venture Partners, Merck Global Health Innovation Fund, Partners & Partners and 4 more.
Who are Aviir's competitors?
Competitors of Aviir include Linkage Biosciences, VitaPath Genetics, Navigenics, MicroPhage, Crescent Diagnostics and 9 more.
You May Also Like
Genera Biosystems is a development phase company that designs, develops and produces and clinically effective human molecular diagnostics with a focus on women's health.
Helix Diagnostics LLC is pursuing development and commercialization of multiplexed DNA detection systems based on capillary electrophoresis.
MicroPhage's mission is to be a worldwide pioneer in rapid bacterial diagnostics, in both bacterial identification and antibiotic susceptibility/resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics.
Integrative Diagnostics is a early cancer detection company founded by Leroy Hood.
3PrimiR is researching how mutations in micro RNA molecules can be used in cancer diagnostics.
Columbia BioSystems Inc. is a company engaged in molecular Nano-diagnostics using Molecularly Imprinted Polymers (MIPs) for the rapid detection of pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA) , Anthrax, HIV, and Trypanosomiasis (sleeping sickness). The company uses MIPs to bind to proteins and, upon binding, change color thereby signaling the presence of the bacteria, virus or parasite.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.